导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.33% | 433/1050 |
| 近一周 | -1.74% | 301/1104 |
| 近一月 | -3.03% | 350/1102 |
| 近一季 | 1.62% | 186/1092 |
| 近半年 | -1.99% | 477/1070 |
| 近一年 | 7.77% | 397/1018 |
| 近两年 | 57.40% | 450/926 |
| 近三年 | 33.03% | 369/834 |
| 成立以来 | 332.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.40% 454/1070 |
6.18% 604/1101 |
- - |
- - |
| 2025 | 27.40% 524/1065 |
4.09% 471/1014 |
-0.42% 720/1038 |
23.92% 483/1050 |
-0.81% 487/1065 |
| 2024 | 9.18% 308/1011 |
-0.37% 334/960 |
-0.74% 357/983 |
13.55% 342/991 |
-2.77% 515/1011 |
| 2023 | -14.50% 502/952 |
2.41% 481/880 |
-4.30% 480/895 |
-6.19% 375/915 |
-7.00% 676/952 |
| 2022 | -18.85% 293/867 |
-17.35% 387/773 |
9.40% 288/806 |
-11.48% 345/845 |
1.38% 364/867 |
| 2021 | -8.39% 467/740 |
-3.84% 295/580 |
6.59% 435/659 |
-12.83% 573/704 |
2.53% 332/740 |
| 2020 | 60.93% 190/554 |
10.79% 40/419 |
24.24% 206/466 |
6.81% 326/517 |
9.46% 373/554 |
| 2019 | 51.84% 136/410 |
24.76% 719/1149 |
0.93% 241/1231 |
13.89% 56/390 |
5.88% 316/410 |
| 2018 | -15.91% 32/349 |
- - |
- - |
- - |
-9.40% 251/1080 |
| 2017 | 30.84% 35/285 |
- - |
- - |
- - |
- - |
| 2016 | -11.63% 72/205 |
- - |
- - |
- - |
- - |
| 2015 | 54.55% 18/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 南方天元新产业股票(LOF) VS. 东吴新产业精选股票A(580008) |